After a thorough deliberation, the E-NITAG recommended postponed the decision of introducing a single-dose HPV vaccine until sufficient evidence is gathered. The ENITAG agreed to re-examine its recommendation after additional review of evidence on the single-dose schedule of the HPV vaccine in its next meeting.

  • Agenda & Minutes
  • Africa
  • Ethiopia
  • Human papillomavirus (HPV)